{"url_path":"/sec/cpix/8-k/2026-07-01/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 ****Other Events**.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1087294/0001104659-26-079871-index.html","accession_number":"0001104659-26-079871","cik":"0001087294","ticker":"CPIX","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1087294/0001104659-26-079871-index.html","primary_entity_key":"0001087294","primary_entity_name":"CUMBERLAND PHARMACEUTICALS INC"},"word_count":373,"has_tables":true,"body_markdown":"**Item 8.01****Other Events**.\n\n \n\nOn July 1, 2026, the Company issued a press release\nannouncing the closing of the Transaction. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form\n8-K.\n\n \n\n**Forward-Looking Statements**\n\n \n\nThis Current Report on Form 8-K and the attached\nexhibits contain “forward-looking statements” within the meaning of the federal securities laws. These forward-looking statements\ninclude statements concerning the Company’s outlook for the future, as well as other statements of beliefs, future plans and strategies\nor anticipated events, and similar expressions concerning matters that are not historical facts. These statements can be identified by\nthe use of forward-looking terminology such as “believes,” “continues,” “estimates,” “anticipates,”\n“expects,” “plans,” “intends,” “may,” “could,” “might,” “will,”\n“should,” or the negative thereof or other variations thereon or other comparable terminology. The forward-looking statements\nincluded in this Current Report on Form 8-K or the attached exhibits are based on management’s current expectations and assumptions\nabout future events, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and\ncould cause actual results to differ materially from those expressed in, or implied by, the forward-looking statements. These risks and\nuncertainties include, but are not limited to, the following: an increase in the anticipated amount of costs, fees, expenses and other\ncharges related to the Transaction; risks arising from the diversion of management’s attention from the Company’s ongoing\nbusiness operations; risks associated with the use of proceeds from the Transaction and the Company’s ability to identify and realize\nbusiness opportunities following the Transaction; risks of losing key personnel, customers, distributors, or suppliers; protection of\nthe Company’s intellectual property; government policies and regulations, including, but not limited to those affecting the Company’s\nindustry; and the matters discussed under “Item 1A. Risk Factors” of the Company’s Annual Report on Form 10-K for the\nfiscal year ended December 31, 2025, as amended and updated from time to time in the Company’s subsequent filings with the SEC.\nReaders are cautioned not to place undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date\nthat it was made and the Company undertakes no obligation to update any forward-looking statement, whether as a result of new information\nor otherwise."}